Miacalcin Injection Use at Hilo Medical Center

Enduring Material CME

Hilo Medical Center is accredited by the Hawaii Medical Association to provide continuing medical education for Physicians.

Hilo Medical center designates this live activity for a maximum of .50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please complete the evaluation and the post test:

Question Title

* 1. Will information gained from this program result in enhancing optimal patient care?

Yes

Question Title

* 2. if you answered yes, please list change(s) you intend to make in your practice as a result of this program:

Question Title

* 3. Please rate your confidence in implementing these changes:

High Confidence

Moderate Confidence

Low/No Confidence

Not Applicable

Question Title

* 4. Please identify any barriers you perceive in implementing these changes(select ALL that applies)

Cost

Insurance/reimbursement issues

Lack of time to assess/counsel patient's

Patient compliance issues

Lack of administrative support/resources

Lack of consensus of professional guidelines.

Question Title

* 5. How will you address these barriers to implement changes in knowledge and behavior?

Question Title

* 6. The material was presented at an appropriate level

Yes

Question Title

* 7. I have gained knowledge that will improved patient care

Yes

Question Title

* 8. The program met my expectations in accomplishing the stated educational objectives

Yes

Question Title

* 9. The program content was objective, balanced and free from commercial bias or influents

Yes

Question Title

* 10. How can this program be improved? (Please list both strengths and weaknesses)

Question Title

* 11. Based on your educational needs, please provide us with suggestions for future program topics and formats:

ACCME requirement Element 2.4 - Educational Activity Evaluation
All educational activities must be evaluated by the CME Committee to determine effectiveness in meeting identified educational needs and, intended purpose/objectives and to determine success in improving participant knowledge and patient care.

Question Title

* 12. Tachyphylaxis develops to Miacalcin injection during treatment for hypercalcemia within:

12 hours

48 hours.

72 hours

7 days

Question Title

* 13. The cost of Miacalcin has increased by approximately _____ over the last several years:

10%

200%

500%

4000%.

Question Title

* 14. Miacalcin injection should be reserved for treating severe hypercalcemia (calcium>14mg/dL)

True.

False

Question Title

* 15. Nasal Calcitonin is not effective in treating osteoporosis

True

False

Question Title

* 16. Usual starting dose of Miacalcin for treating hypercalcemia:

2 mg/kg every 12 hours

4 mg/kg every 12 hours.

8 mg/kg every 12 hours

10 mg/kg every 12 hours